ProCE Banner Activity

快速启动抗逆转录病毒治疗:中国的新数据和持续进展

Clinical Thought

在 2022 年 IDWeek,研究人员报告了随机 START 试验的长期分析的新发现,该试验比较了即时与延迟启动 ART。研究结果继续强调了早期和晚期 ART 启动的益处,也是对中国成功缩短新确诊患者启动 ART 时间的策略的支持。

Share

Faculty

Yan Zhao

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

由 Gilead Sciences, Inc.、Janssen Products, LP 旗下的 Janssen Therapeutics 和 ViiV Healthcare 提供教育资助。

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

医学博士 Yan Zhao 没有要披露的相关财务信息。